Welcome to LookChem.com Sign In|Join Free

CAS

  • or
MilbeMycin A4 OxiMe, a semi-synthetic macrocyclic lactone, is derived from the oxidation and oximation of a mixture of milbemycin A4. It is the primary component (~70%) in the commercial product, milbemycin oxime, which is specifically formulated to target endoand exo-parasite infections. MilbeMycin A4 OxiMe functions by activating glutamate-sensitive chloride channels in the neurons of invertebrates, causing hyperpolarization and paralysis, ultimately disrupting signal transmission.

93074-04-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 93074-04-5 Structure
  • Basic information

    1. Product Name: MilbeMycin A4 OxiMe
    2. Synonyms: MilbeMycin A4 OxiMe;5-OxoMilbeMycin A4 oxiMe
    3. CAS NO:93074-04-5
    4. Molecular Formula: C32H45NO7
    5. Molecular Weight: 555.71
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 93074-04-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: MilbeMycin A4 OxiMe(CAS DataBase Reference)
    10. NIST Chemistry Reference: MilbeMycin A4 OxiMe(93074-04-5)
    11. EPA Substance Registry System: MilbeMycin A4 OxiMe(93074-04-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 93074-04-5(Hazardous Substances Data)

93074-04-5 Usage

Uses

Used in Veterinary Medicine:
MilbeMycin A4 OxiMe is used as an anti-parasitic agent for treating endoand exo-parasite infections in animals. Its mode of action involves the opening of glutamate-sensitive chloride channels in invertebrate neurons, leading to paralysis by hyperpolarization and signal transfer blocking, which effectively eliminates parasites.
Used in Pharmaceutical Industry:
MilbeMycin A4 OxiMe is used as the major component in the commercial product milbemycin oxime, which is specifically designed to combat various parasitic infections. Its effectiveness in targeting parasites makes it a valuable asset in the development of anti-parasitic medications for both veterinary and human applications.

Check Digit Verification of cas no

The CAS Registry Mumber 93074-04-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,0,7 and 4 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 93074-04:
(7*9)+(6*3)+(5*0)+(4*7)+(3*4)+(2*0)+(1*4)=125
125 % 10 = 5
So 93074-04-5 is a valid CAS Registry Number.

93074-04-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-ketomilbemycin A4 5-oxime

1.2 Other means of identification

Product number -
Other names Milbemycin A4 Oxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:93074-04-5 SDS

93074-04-5Downstream Products

93074-04-5Relevant articles and documents

METHOD FOR SYNTHESIZING MILBEMYCIN OXIME

-

Paragraph 0022-0033, (2017/04/14)

The present invention provides a method for synthesizing Milbemycin oxime. The method comprises the following steps. (1) Oxidizing reaction: oxidizing Milbemycin, using hypochlorite or chlorite as oxidizers and piperidine nitrogen oxygen free radicals as the catalyst and halide as the catalyst promoter. The oxidation reaction is conducted in a dichloromethane solvent for 0.5-4 hours at ?5-15° C. to produce the intermediate product Milbemycin ketone. (2) Oximation reaction: reacting the Milbemycin ketone with a hydroxylamine hydrochloride oximation agent in a 1,4-dioxane reaction solvent for 10-16 hours at 25-35° C. to obtain Milbemycin oxime. The method provided by the present invention realized the industrial production of Milbemycin oxime for the first time domestically. Moreover, the yield of the prepared product is higher than competing products both at home and abroad.

Synthesis of 5-keto-5-oxime derivatives of milbemycins and their activities against microfilariae.

Tsukamoto,Sato,Mio,Sugai,Yanai,Kitano,Muramatsu,Nakada,Ide

, p. 2615 - 2621 (2007/10/02)

Starting from milbemycin D (1), milbemycin A4 (2) and milbemycin A3 (3), a series of 5-keto-5-oxime derivatives were synthesized by selective oximation at the alpha,beta-conjugated carbonyl function of the 5-ketomilbemycins (4-6). The activities of the synthesized compounds were studied in dogs naturally infested with microfilariae of Dirofilaria immitis. The 5-keto-5-oximes of milbemycin D (7), A4 (8) and A3 (9) had quite high efficacy to control the microfilariae and more potency than their parents, while the 5-O-acyl oximes (11-15) also exhibited high activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 93074-04-5